MDM4 is a rational target for treating breast cancers with mutant p53

Miranda, P.J.; Buckley, D.; Raghu, D.; Pang, J.M.B.; Takano, E.A.; Vijayakumaran, R.; ... ; Haupt, Y. (2017)

Article / Letter to editor

• MDM4
• breast cancer
• mutant p53
• p27
• TNBC

• All authors: Miranda, P.J.; Buckley, D.; Raghu, D.; Pang, J.M.B.; Takano, E.A.; Vijayakumaran, R.; Teunisse, A.F.A.S.; Posner, A.; Procter, T.; Herold, M.J.; Gamell, C.; Marine, J.C.; Fox, S.B.; Jochemsen, A.; Haupt, S.; Haupt, Y.
• Date: 2017-04-30
• Journal: Journal of Pathology
• Volume: 241
• Issue: 5
• Pages: 661 - 670
• DOI: doi:10.1002/path.4877